Fairmount Funds Management as of June 30, 2021
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 19 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 15.0 | $37M | 1.3M | 28.46 | |
| Zogenix Com New | 14.0 | $34M | 2.0M | 17.28 | |
| Axsome Therapeutics (AXSM) | 8.7 | $21M | 313k | 67.46 | |
| Argenx Se Sponsored Adr (ARGX) | 8.6 | $21M | 69k | 301.07 | |
| Iovance Biotherapeutics (IOVA) | 5.4 | $13M | 506k | 26.02 | |
| Instil Bio | 5.4 | $13M | 674k | 19.32 | |
| Allakos (ALLK) | 5.3 | $13M | 152k | 85.37 | |
| Cogent Biosciences (COGT) | 5.2 | $13M | 1.6M | 8.11 | |
| Amarin Corp Spons Adr New (AMRN) | 4.6 | $11M | 2.5M | 4.38 | |
| ACADIA Pharmaceuticals (ACAD) | 4.2 | $10M | 424k | 24.39 | |
| Therapeutics Acquisition Cor Com Cl A | 3.6 | $8.9M | 864k | 10.27 | |
| Trillium Therapeutics Com New | 3.6 | $8.7M | 896k | 9.70 | |
| Catabasis Pharmaceuticals In Com New | 3.5 | $8.6M | 4.1M | 2.11 | |
| Amicus Therapeutics (FOLD) | 3.5 | $8.6M | 889k | 9.64 | |
| Enanta Pharmaceuticals (ENTA) | 3.2 | $7.8M | 178k | 44.01 | |
| Global Blood Therapeutics In | 3.0 | $7.4M | 210k | 35.02 | |
| Keros Therapeutics (KROS) | 2.6 | $6.3M | 149k | 42.47 | |
| Miragen Therapeutics (VRDN) | 0.3 | $642k | 35k | 18.29 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $549k | 84k | 6.54 |
